OncoLens announced today that it has been chosen out of hundreds of applicants as one of the top 36 rising star technology companies in the Southeast that will present on stage at Venture Atlanta 2019...

OncoLens, a pioneer in automated cancer treatment planning software solutions, has appointed Carla Balch to its board of directors. Balch, CEO of Inteliquet (formerly TransMed Systems), a leading prov...

(Atlanta) OncoLens, a clinical decision software that focuses on oncology (cancer care), has closed a $1.35 million seed round led by BIP Capital and Atlanta Technology Angels (ATA).  The platform...